
Barrett's Esophagus Market Report 2026
Global Outlook – By Type (No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types), By Treatment (Medication, Endoscopic Therapy, Surgery, Other Treatments), By Route Of Administration (Oral, Parenteral, Rectal, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2026-2035
Barrett's Esophagus Market Overview
• Barrett's Esophagus market size has reached to $6.71 billion in 2025 • Expected to grow to $9.52 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Catalyst For The Growth In Barrett's Esophagus Market • Market Trend: Pioneering Device Developments Driving The Barrett Esophagus Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Barrett's Esophagus Market?
Barrett's esophagus is the medical term for a condition in which acid reflux harms the flat pink lining of the swallowing tube, which connects the mouth to the stomach. This affects the lining, causing it to thicken and turn red. Barrett's esophagus is more resistant to stomach acid than squamous cells and intestinal cells, indicating that tissue alterations take place to shield the esophagus from acid exposure. This illness affects men more often than women and white people. The main barrett’s esophagus types are no dysplasia, low-grade dysplasia, high grade dysplasia, and others. No dysplasia refers to column-like cells, including goblets that are blue and filled with mucin. The various treatments are medication, endoscopic therapy, surgery, and others with route of administration such as oral, parenteral, rectal, and others. The various distribution channels are hospital pharmacy, retail pharmacy, online pharmacy, and others.
What Is The Barrett's Esophagus Market Size and Share 2026?
The barrett's esophagus market size has grown strongly in recent years. It will grow from $6.71 billion in 2025 to $7.17 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising incidence of gastroesophageal reflux disease, increased awareness of esophageal cancer risk, availability of endoscopic diagnostic tools, expansion of gastroenterology specialty care, improved clinical surveillance protocols.What Is The Barrett's Esophagus Market Growth Forecast?
The barrett's esophagus market size is expected to see strong growth in the next few years. It will grow to $9.52 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing adoption of advanced endoscopic imaging, growing use of precision ablation technologies, rising focus on early intervention strategies, expansion of outpatient endoscopic treatments, increasing research into disease progression prevention. Major trends in the forecast period include increasing adoption of endoscopic surveillance programs, rising use of ablation therapies, growing focus on early dysplasia detection, expansion of minimally invasive treatment options, enhanced emphasis on long-term disease monitoring.Global Barrett's Esophagus Market Segmentation
1) By Type: No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types 2) By Treatment: Medication, Endoscopic Therapy, Surgery, Other Treatments 3) By Route Of Administration: Oral, Parenteral, Rectal, Other Routes Of Administration 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels Subsegments: 1) By No Dysplasia: Surveillance Management, Endoscopic Monitoring 2) By Low-Grade Dysplasia: Endoscopic Surveillance, Ablation Therapies 3) By High-Grade Dysplasia: Endoscopic Mucosal Resection (EMR), Radiofrequency Ablation (RFA) 4) By Other Types: Mixed Dysplasia, Rare VariantsWhat Is The Driver Of The Barrett's Esophagus Market?
Increased chances of esophageal cancer are expected to propel the growth of barrett esophagus market going forward. Esophageal cancer refers to a type of cancer that affects the esophagus, a long, hollow tube that connects the throat to the stomach. The rise in esophageal cancer occurs in patients with Barrett's esophagus with dysplasia. However, the chance of developing esophageal cancer is higher in people with high-grade dysplasia in Barrett's esophagus. For instance, in 2023, according to the American Cancer Society, a US-based cancer-fighting organization that provides patient support, research, and advocacy for cancer care, esophageal cancer will affect an estimated 21,560 people in 2023, compared to 20,640 people affected in 2022. Therefore, an increase in the chance of esophageal cancer is driving the growth of barrett esophagus market.Key Players In The Global Barrett's Esophagus Market
Major companies operating in the barrett's esophagus market are F. Hoffmann-La Roche Ltd., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Medtronic PLC, Merck KGaA, Boston Scientific Corporation, Olympus Corporation, Eisai Co. Ltd., Steris plc, Aurobindo Pharma Limited, Cook Medical Inc., Endo International plc, Sun Pharmaceutical Industries Limited, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Phathom Pharmaceuticals Inc., EndoGastric Solutions Inc., NinePoint Medical Inc., Mederi Therapeutics Inc., Zydus Group, Johnson & Johnson Private LimitedGlobal Barrett's Esophagus Market Trends and Insights
Major companies operating in the Barrett esophagus market are focusing on developing innovative solutions, such as advanced wireless reflux diagnostic systems, to meet the rising demand for more accurate, patient-friendly, and long-duration monitoring technologies. Wireless pH-capsule testing systems provide extended reflux monitoring without the discomfort of traditional catheter-based methods, offering improved patient compliance and more reliable diagnostic data for conditions like GERD that contribute to Barrett esophagus. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, launched the new alpHaONE wireless pH-capsule reflux testing diagnostic system designed for diagnosing gastroesophageal reflux disease (GERD). The system can monitor for up to 96 hours and has a small design with larger buttons and a fail-safe capsule delivery method. The system includes a software application with a virtual instruction program and user-customizable symptom buttons.What Are Latest Mergers And Acquisitions In The Barrett's Esophagus Market?
In January 2023, ProPhase Labs, Inc., a U.S.-based diagnostics, genomics, and biotech company, acquired the rights to the BE Smart Esophageal Pre Cancer diagnostic screening test from Stella Diagnostics, Inc., for an undisclosed amount. With this acquisition, ProPhase aims to commercialize a molecular diagnostic tool for early detection of esophageal cancer in patients with Barrett’s esophagus, enabling risk stratification and potentially reducing unnecessary endoscopies. Stella Diagnostics is a U.S.-based molecular diagnostics company that develops first-line diagnostic tools for severe esophageal disease.Regional Outlook
North America was the largest region in the barrett esophagus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the barrett's esophagus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the barrett's esophagus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Barrett's Esophagus Market?
The barrett esophagus market includes revenues earned by entities by providing pathology services, treatment services and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Barrett's Esophagus Market Report 2026?
The barrett's esophagus market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the barrett's esophagus industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Barrett's Esophagus Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.17 billion |
| Revenue Forecast In 2035 | $9.52 billion |
| Growth Rate | CAGR of 6.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Treatment, Route Of Administration, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Medtronic PLC, Merck KGaA, Boston Scientific Corporation, Olympus Corporation, Eisai Co. Ltd., Steris plc, Aurobindo Pharma Limited, Cook Medical Inc., Endo International plc, Sun Pharmaceutical Industries Limited, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Phathom Pharmaceuticals Inc., EndoGastric Solutions Inc., NinePoint Medical Inc., Mederi Therapeutics Inc., Zydus Group, Johnson & Johnson Private Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
